Anne Blanchard Selected Research

Gitelman Syndrome

11/2022	Parathyroid hormone and phosphate homeostasis in patients with Bartter and Gitelman syndrome: an international cross-sectional study.
1/2022	Calcium pyrophosphate crystal deposition in a cohort of 57 patients with Gitelman syndrome.
11/2020	Investigation of Vestibular Function in Adult Patients with Gitelman Syndrome: Results of an Observational Study.
11/2020	Adrenal adaptation in potassium-depleted men: role of progesterone?
7/2020	[Bartter-Gitelman syndromes].
1/2019	Resistance to Insulin in Patients with Gitelman Syndrome and a Subtle Intermediate Phenotype in Heterozygous Carriers: A Cross-Sectional Study.
1/2017	Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
12/2016	Functionomics of NCC mutations in Gitelman syndrome using a novel mammalian cell-based activity assay.
2/2015	Indomethacin, amiloride, or eplerenone for treating hypokalemia in Gitelman syndrome.
2/2014	Plasma soluble (pro)renin receptor is independent of plasma renin, prorenin, and aldosterone concentrations but is affected by ethnicity.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anne Blanchard Research Topics

Disease

14	Gitelman Syndrome 11/2022 - 05/2005
10	Neoplasms (Cancer) 01/2022 - 07/2003
9	Hypertension (High Blood Pressure) 01/2022 - 12/2008
6	Hyperaldosteronism (Conn Syndrome) 10/2020 - 02/2011
6	Breast Neoplasms (Breast Cancer) 08/2015 - 12/2003
5	Bartter Syndrome (Syndrome, Bartter) 11/2022 - 01/2008
5	Septic Shock (Toxic Shock Syndrome) 01/2013 - 03/2002
5	Dent Disease 04/2011 - 01/2006
4	Hyperparathyroidism 11/2022 - 11/2012
4	Hypercalciuria 07/2020 - 01/2008
4	Hypokalemia 07/2020 - 09/2005
3	Cushing Syndrome 01/2022 - 09/2011
3	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2022 - 09/2011
3	Fibrosis (Cirrhosis) 10/2020 - 07/2008
3	Essential Hypertension 10/2020 - 02/2011
3	Alkalosis 07/2020 - 09/2005
3	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 01/2019 - 05/2006
3	Acromegaly 06/2012 - 07/2008
2	Osteoporosis 01/2022 - 09/2005
2	Pheochromocytoma 01/2022 - 01/2020
2	Hypernatremia 01/2022 - 06/2003
2	Paraganglioma (Paragangliomas) 01/2022 - 01/2020
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 11/2021
2	Bone Resorption 12/2021 - 01/2017
2	COVID-19 01/2021 - 01/2021
2	Heart Failure 10/2020 - 05/2013
2	Hypovolemia 07/2020 - 12/2008
2	Chondrocalcinosis (Pseudogout) 01/2020 - 09/2005
2	type 3 Bartter syndrome 08/2017 - 09/2014
2	Acidosis 01/2017 - 07/2008
2	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 01/2016 - 06/2003
2	Hyponatremia 05/2013 - 12/2008
2	Oculocerebrorenal Syndrome (Lowe Syndrome) 04/2011 - 07/2008
2	Primary Hyperoxaluria (Oxaluria, Primary) 07/2008 - 01/2008
2	Nephrocalcinosis 07/2008 - 01/2008
2	Fanconi Syndrome (Syndrome, Fanconi) 01/2006 - 04/2004
2	Shock 06/2003 - 03/2002
1	Hyperparathyroidism 2 11/2022
1	Kidney Calculi (Kidney Stone) 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Joint Diseases (Joint Disease) 01/2022

Drug/Important Bio-Agent (IBA)

15	SaltsIBA 01/2022 - 10/2008
9	ThiazidesIBA 01/2022 - 05/2005
9	Vasopressins (Vasopressin)IBA 12/2016 - 03/2002
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2009
8	SodiumIBA 07/2020 - 07/2008
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2012
6	AldosteroneIBA 10/2020 - 02/2011
5	CalciumIBA 11/2022 - 12/2008
5	ReninIBA 01/2020 - 02/2011
4	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 01/2020
4	PotassiumIBA 11/2020 - 02/2011
4	Furosemide (Lasix)FDA LinkGeneric 07/2020 - 07/2011
4	MagnesiumIBA 02/2015 - 07/2008
3	Phosphates (Orthophosphate)IBA 11/2022 - 06/2012
3	Hormones (Hormone)IBA 01/2022 - 07/2003
3	Amiloride (Midamor)FDA LinkGeneric 01/2022 - 07/2011
3	Protons (Proton)IBA 11/2021 - 11/2009
3	Member 3 Solute Carrier Family 12IBA 11/2020 - 09/2005
3	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 10/2020 - 12/2008
3	dirhodium tetraacetate (DRTA)IBA 01/2019 - 05/2006
3	ChloridesIBA 08/2017 - 11/2009
3	steroid receptor RNA activatorIBA 12/2015 - 01/2009
3	Insulin-Like Growth Factor I (IGF-1)IBA 06/2012 - 07/2008
3	Biological ProductsIBA 10/2009 - 09/2005
2	Parathyroid Hormone (Parathormone)IBA 11/2022 - 01/2020
2	GlucocorticoidsIBA 01/2022 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2019
2	AntibodiesIBA 01/2021 - 10/2013
2	Amlodipine (Norvasc)FDA LinkGeneric 10/2020 - 12/2016
2	Irbesartan FDA LinkGeneric 10/2020 - 12/2016
2	DiureticsIBA 10/2020 - 07/2011
2	Potassium Sparing DiureticsIBA 07/2020 - 02/2015
2	CatecholaminesIBA 01/2020 - 01/2013
2	SteroidsIBA 01/2020 - 01/2020
2	Insulin (Novolin)FDA Link 01/2020 - 01/2019
2	AndrogensIBA 01/2020 - 07/2003
2	Chloride Channels (Chloride Channel)IBA 08/2017 - 01/2006
2	Calcitriol (Calcijex)FDA LinkGeneric 01/2016 - 06/2012
2	ApelinIBA 01/2016 - 05/2013
2	Cisplatin (Platino)FDA LinkGeneric 08/2015 - 01/2015
2	Etoposide (VP 16)FDA LinkGeneric 08/2015 - 01/2015
2	Tamoxifen FDA LinkGeneric 08/2015 - 01/2015
2	Phenobarbital (Luminal)FDA Link 08/2015 - 01/2015
2	Claudin-1IBA 08/2015 - 01/2015
2	Tight Junction ProteinsIBA 08/2015 - 01/2015
2	erucylphosphocholineIBA 01/2013 - 02/2012
2	ElectrolytesIBA 01/2013 - 06/2012
2	Epithelial Sodium ChannelsIBA 07/2011 - 07/2008
2	Uric Acid (Urate)IBA 07/2008 - 04/2004
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	CyclodextrinsIBA 01/2022
1	diphosphoric acid (pyrophosphoric acid)IBA 01/2022
1	Calcium PyrophosphateIBA 01/2022
1	NormetanephrineIBA 01/2022
1	ProlactinIBA 01/2022
1	AutoantibodiesIBA 01/2022

Therapy/Procedure

4	Therapeutics 01/2020 - 12/2008
2	Aftercare (After-Treatment) 07/2011 - 12/2008
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2022